Orion Temozolomide Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

orion temozolomide

orion laboratories (nz) ltd - temozolomide 180mg - capsule - 180 mg - active: temozolomide 180mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

Orion Temozolomide Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

orion temozolomide

orion laboratories (nz) ltd - temozolomide 20mg - capsule - 20 mg - active: temozolomide 20mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

Orion Temozolomide Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

orion temozolomide

orion laboratories (nz) ltd - temozolomide 250mg - capsule - 250 mg - active: temozolomide 250mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

Orion Temozolomide Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

orion temozolomide

orion laboratories (nz) ltd - temozolomide 5mg - capsule - 5 mg - active: temozolomide 5mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint green sb-4020 titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

METHOTREXATE ORION TABLETS 2.5 MG Singapur - İngilizce - HSA (Health Sciences Authority)

methotrexate orion tablets 2.5 mg

orion pharma (sg) pte. ltd. - methotrexate disodium eqv methotrexate - tablet - methotrexate disodium eqv methotrexate 2.5mg

Orion Laboratories TRICLOSAN 1% w/v PRE-OP WASH triclosan application tube Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

orion laboratories triclosan 1% w/v pre-op wash triclosan application tube

orion laboratories pty ltd t/a perrigo australia - triclosan, quantity: 10 mg/ml - application - excipient ingredients: edetate sodium; methyl hydroxybenzoate; dibasic sodium phosphate; purified water; citric acid; ethanol; sodium lauryl sulfate; fragrance (perfume); glycerol; cocamide dea; coconut oil; diethanolamine - a foaming emolient antiseptic soap for pre-operative washing to cleanse and disinfect the skin.

ORION HEXACHLOROPHANE 3% CLEANSING LOTION hexachlorophene 30mg/g Lotion Bottle Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

orion hexachlorophane 3% cleansing lotion hexachlorophene 30mg/g lotion bottle

orion laboratories pty ltd t/a perrigo australia - hexachlorophene, quantity: 30 mg/g - lotion - excipient ingredients: sodium lauryl sulfate; citric acid; methyl hydroxybenzoate; ethanol; purified water; dibasic sodium phosphate heptahydrate; fragrance (perfume); glycerol; cocamide dea; coconut oil; diethanolamine - disinfection of skin.

ORION SORBI SORBITOL SOLUTION (70%) BP NON CRYSTALLISING Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

orion sorbi sorbitol solution (70%) bp non crystallising

orion laboratories pty ltd t/a perrigo australia - sorbitol solution (70 per cent) (non-crystallising) -